CAO, Ziyi; SUI, Eryu; WU, Yidan. Behavior and Consequences of COVID-19-related Voluntary Disclosure: Evidence from Pharmaceutical Companies. BCP Business & Management, [S. l.], v. 31, p. 378–391, 2022. DOI: 10.54691/bcpbm.v31i.2653. Disponível em: https://bcpublication.org/index.php/BM/article/view/2653. Acesso em: 24 jun. 2026.